A single pair of oligonucleotide primers was used for polymerase chain reaction amplification of a 212-or 215-bp region of Escherichia coli Shiga-like toxin (SLT) genes from crude fecal culture extracts. Genes were typed by hybridization of the polymerase chain reaction products to SLT-I-or SLT-II-specific oligonucleotide probes. The procedure was capable of detecting fewer than 10 SLT-producing E. coli organisms per ml of culture against a background of more than 109 other organisms per ml and provides a rapid and sensitive means of screening primary fecal cultures for the presence of such strains. When this procedure was used to test primary cultures from gut contents or feces from various patient groups, including apparently healthy infants, approximately half of all samples yielded positive results for SLT-I and/or SLT-II sequences.
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Escherichia coli strains producing one or more Shiga-like toxins (SLTs) are capable of causing diseases including diarrhea, hemorrhagic colitis, and hemolytic-uremic syndrome in humans (12, 15, 22) , as well as edema disease in piglets (7) . The existence of two major types of SLT (SLT-I and SLT-II) has been demonstrated on the basis of antigenic and nucleotide sequence variations (9, 24, 27) , and these toxins were shown to be encoded on temperate bacteriophages (16, 27) . In recent years, a number of chromosomally encoded variants of SLT-II have been detected in E. coli isolates from both humans and domestic animals (5, 6, 8, 18, 26) . Also, we have recently reported the sequence of a chromosomally encoded variant of SLT-I (17) .
Initially, laboratory detection of SLTs was dependent on demonstration of the presence of a Vero cell cytotoxin in extracts of feces or E. coli isolates, which could be neutralized by antibodies to the respective SLT type (12) . Strains could also be tested for the presence of the various SLT genes by hybridization to DNA or oligonucleotide probes (3, 14, 21, 25, 27) or by polymerase chain reaction (PCR) amplification (2, 10, 19) . However, testing of individual isolates may result in poor sensitivity of detection, unless very large numbers of isolates are analyzed. It has been shown that in cases of hemolytic-uremic syndrome, fewer than 1% of E. coli isolates from a given fecal sample may be SLT positive (22 For direct examination of fecal cultures by PCR, approximately 500 mg of feces was inoculated into 10 ml of Luria-Bertani broth (13) 5 '-ATACAGAG(GA)G(GA)ATTTCGT-3' and 5'-TGATGA TG(AG)CAATTCAGTAT-3'. The nucleotides in parentheses denote positions at which two alternative nucleotides were incorporated during oligonucleotide synthesis to accommodate known sequence variations between various SLT types. This enabled the same primer set to be used for amplification of a 215-bp region corresponding to nucleotides 586 to 800 of the A subunit coding sequence of SLT-I or a 212-bp region corresponding to nucleotides 583 to 794 of the A subunit coding region of SLT-II (including all SLT-II variants). SLT-I-and SLT-II-related PCR products were distinguished by hybridization with two oligonucleotide probes (5'-AGAACGCCCACTGAGATCATC-3', which is specific for SLT-I, and 5'-ATACACAGGGAGCAGTlITC AGA-3', which is specific for SLT-II and SLT-II variants).
To confirm the specificity of the PCR employing these primers, crude extracts were prepared as described above from cultures of E. coli C600, E. coli C600 lysogenized with the SLT-I-encoding phage H19B (27) , E. coli C600 lysogenized with the SLT-II-encoding phage 933W (9), an E. coli O111:H-strain carrying both SLT-I-and SLT-II-related genes (17) , and an E. coli OX3:H21 strain carrying two SLT-II-related genes (18) . Samples (10 pul) of each extract gelatin-0.1% Tween 20-0.1% Nonidet P-40. Samples were subjected to 35 PCR cycles, each consisting of 1 min of denaturation at 94°C, 3 min of annealing at 47°C, and 4 min of elongation at 72°C. PCR mixes were electrophoresed on 2% agarose gels and stained with ethidium bromide (Fig. 1) . A discrete PCR product of the expected size was seen for all templates except the negative control (no DNA template) and the E. coli C600 extract. DNA from replicates of this gel was then transferred to nylon filters (Hybond N+; Amersham, Little Chalfont, Buckinghamshire, England) according to the method of Southern (23), fixed, prehybridized, and then hybridized overnight at 45°C with DIG-labelled SLT-Iand SLT-II-specific oligonucleotide probes. The hybridization mix contained 5x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 1% sodium dodecyl sulfate, 0.5% bovine serum albumin, 2 mM Na4 pyrophosphate, and 0.5% polyvinylpyrrolidone. Filters were subjected to two 30-min washes in 5 x SSC at 500C followed by one 30-min wash at room temperature in 2x SSC, and labelled bands were detected with a DIG-DNA detection kit (Boehringer Mannheim). The SLT-I probe hybridized strongly with the PCR products from the C600(H19B) and O111:H-extracts, while the SLT-II probe reacted strongly with the extracts from C600(933W), O111:H-, and OX3:H21, thereby confirming the specificity of the two oligonucleotides (Fig. 2) . Weak PCR products of greater than the expected size which were seen for the C600 template (Fig. 1, lane 2) did not react with either SLT probe, suggesting that these are due to spurious priming. Such nonspecific amplicons were not seen for either the C600(H19B) or the C600(933W) template, presumably because the primers have much higher affinity for the correct (SLT-specific) target sequence present in those samples. The nonspecific amplicons observed for the C600 template could be eliminated by increasing the annealing temperature of the PCR to 52°C, but at this temperature, sensitivity was compromised, as the yield of PCR product obtained with the known SLT-positive templates was reduced (result not shown).
To determine the sensitivity of the PCR assay when crude extracts of primary fecal cultures were used as a template, 1-ml aliquots of a known SLT-negative fecal culture (containing >10i organisms per ml) were seeded with 100-,ul aliquots from serial 10-fold dilutions of a culture from the SLT-positive E. coli O111:H-strain referred to above. Crude DNA extracts were prepared as described above, and the samples were subjected to PCR, electrophoresed, and subjected to Southern blot hybridization analysis using the SLT-I-specific oligonucleotide probe (Fig. 3) . The lower limit of detection was approximately 10 CFU of SLTpositive E. coli per ml against a background of >10i organisms (after correction for the volume of each crude DNA extract assayed, this is equivalent to approximately a single SLT-positive organism). Thus, this method could be expected to yield positive results in samples in which SLTpositive organisms constitute only 10-6% of those present.
Bettelheim et al. (1) have previously reported that strains of E. coli producing Vero cell cytotoxins could be isolated from 13 of 46 babies who died from sudden infant death syndrome (SIDS), although the identity of the toxin(s) was not confirmed by antibody neutralization studies. We have recently reported the cloning and nucleotide sequence of a variant SLT-II gene from one of the toxigenic strains isolated in the above-mentioned study (18) . We therefore employed the PCR assay described above to test for the presence of SLT-positive organisms in samples of gut contents (from the small and large bowels) obtained from fresh autopsy specimens of 22 Fig. 4 . A result was scored as positive for SLT-I or SLT-II if a hybridization signal with a fragment of approximately 215 bp was obtained with the respective oligonucleotide probe. Specimen 1 was positive for SLT-II, and specimens 3 and 4 were positive for both SLT-I and SLT-II, while the other specimens were negative for both genes. The PCR-Southern hybridization results for all the samples tested are summarized in Table 1 . Remarkably, SLT-related PCR products were detected in roughly half of the samples from each group. SLT-II-related PCR products were detected in 23 of 55 (42%) samples, 7 of which also contained SLT-I-related amplicons. A further four samples (7%) contained only SLT-I-related PCR products. The higher prevalence of SLT-II than SLT-I is consistent with other studies (22) . Negative results were obtained for 28 of 55 (51%) samples. There was no significant difference in SLT detection rate among any of the four sample groups. Two of the extracts shown in Fig. 4 contained higher-molecular-weight PCR products that reacted weakly with the DIG-labelled oligonucleotide probes. The identity of these species is not known, but they may be a consequence of the presence of SLT-related sequences in other species of bacteria. Indeed, the cloning and sequencing of an SLT-II-related gene from Citrobacterfreundii have recently been reported (20) .
There are several other reports in the literature of PCR assays for the detection of SLT-producing E. coli (2, 10, 19) . Two of these reports (10, 19) because of either low abundance of the SLT-producing organism in the sample or the SLT genes themselves being unstable, as demonstrated by Karch et al. (11) . These workers recommended direct testing of fecal samples to ensure maximum recovery. However, fecal samples could contain substances which inhibit the PCR itself, necessitating extensive purification of the template. Indeed, Brian et al. (2) found that when DNA extracted directly from SLT- The results of this study indicate that when extremely sensitive methods are applied to the analysis of primary cultures, SLT-related genes can be detected in a high proportion of babies (many of whom had no detectable gastrointestinal abnormality). In view of the moderate-to-low intensity of the hybridization signals obtained from the PCR products from the fecal or gut cultures and the fact that, in such cases, distinct PCR products of the expected size were not usually visible on the ethidium bromide-stained gel prior to Southern hybridization analysis, it is probable that many of the specimens contained very low numbers of SLTpositive organisms. Attempts were made to isolate SLTproducing E. coli from some of the PCR-positive primary fecal cultures from the healthy control group. Up to 100 colonies from each of four directly plated fecal samples were tested by dot blot hybridization with an SLT-specific DNA probe, but no positive isolates were detected (result not presented). However, testing this number of colonies would only be expected to yield positive results if the SLT-positive organism accounted for more than 1% of total gut flora; numbers of such organisms are frequently lower than this in cases of severe SLT-related disease such as hemolyticuremic syndrome (22) . The PCR methodology described here had an apparent sensitivity limit 106-fold lower than this.
The presence of SLT-related sequences in approximately half of the fecal samples from apparently healthy babies, as well in a similar proportion of the gut contents of dead infants, complicates the clinical interpretation of the significance of PCR results in isolation. Clearly, very sensitive, direct analytical techniques need to be used to overcome the problems of low pathogen numbers in genuine cases, as well as the known instability of SLT genes in some strains. However, it now appears that such techniques will also detect carriers. Testing direct fecal extracts for the presence of Vero cell cytotoxins might be expected to provide confirmation of the PCR result. However, the presence of frank toxin in the feces of asymptomatic individuals has been reported (4). Indeed, Brian et al. (2) have reported that the feces of an asymptomatic child in their study was positive for SLT-I by both PCR and cytotoxin assay. Moreover, in an earlier study we isolated an SLT-I-producing strain of E. coli from the feces of an apparently healthy infant. This strain was lysogenized by a bacteriophage that was indistinguishable from H19B (16a). It is possible that individuals differ in their susceptibility to SLT-producing organisms or the toxins themselves or that disease-causing SLT-positive strains also produce other virulence factors (e.g., adhesins, enterohemolysins, etc.). Thus, definitive diagnosis of SLT-related disease remains problematic and may necessitate consideration of both laboratory and clinical findings.
